167 related articles for article (PubMed ID: 34976107)
1. Analysis of KRAS Mutation Status Prediction Model for Colorectal Cancer Based on Medical Imaging.
Ren Z; Che J; Wu XW; Xia J
Comput Math Methods Med; 2021; 2021():3953442. PubMed ID: 34976107
[TBL] [Abstract][Full Text] [Related]
2. CT Texture Analysis: A Potential Biomarker for Evaluating KRAS Mutational Status in Colorectal Cancer.
Cao J; Wang GR; Wang ZW; Jin ZY
Chin Med Sci J; 2020 Dec; 35(4):306-314. PubMed ID: 33413746
[TBL] [Abstract][Full Text] [Related]
3. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on CT imaging.
He K; Liu X; Li M; Li X; Yang H; Zhang H
BMC Med Imaging; 2020 Jun; 20(1):59. PubMed ID: 32487083
[TBL] [Abstract][Full Text] [Related]
5. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
[TBL] [Abstract][Full Text] [Related]
6. The value of
Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
[TBL] [Abstract][Full Text] [Related]
7. Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics.
Cao Y; Zhang J; Huang L; Zhao Z; Zhang G; Ren J; Li H; Zhang H; Guo B; Wang Z; Xing Y; Zhou J
Jpn J Radiol; 2023 Nov; 41(11):1236-1246. PubMed ID: 37311935
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning.
Li Y; Eresen A; Shangguan J; Yang J; Benson AB; Yaghmai V; Zhang Z
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3165-3174. PubMed ID: 32779023
[TBL] [Abstract][Full Text] [Related]
9. The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.
Cao Y; Gu J; Yan L; Deng S; Mao F; Cai W; Li H; Liu X; Wang J; Wu K; Cai K
BMC Cancer; 2020 Nov; 20(1):1099. PubMed ID: 33183271
[TBL] [Abstract][Full Text] [Related]
10. Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with
Negreros-Osuna AA; Parakh A; Corcoran RB; Pourvaziri A; Kambadakone A; Ryan DP; Sahani DV
Radiol Imaging Cancer; 2020 Sep; 2(5):e190084. PubMed ID: 33778733
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer.
Oh JE; Kim MJ; Lee J; Hur BY; Kim B; Kim DY; Baek JY; Chang HJ; Park SC; Oh JH; Cho SA; Sohn DK
Cancer Res Treat; 2020 Jan; 52(1):51-59. PubMed ID: 31096736
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer.
Miles KA; Ganeshan B; Rodriguez-Justo M; Goh VJ; Ziauddin Z; Engledow A; Meagher M; Endozo R; Taylor SA; Halligan S; Ell PJ; Groves AM
J Nucl Med; 2014 Mar; 55(3):386-91. PubMed ID: 24516257
[TBL] [Abstract][Full Text] [Related]
13. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.
Ng F; Ganeshan B; Kozarski R; Miles KA; Goh V
Radiology; 2013 Jan; 266(1):177-84. PubMed ID: 23151829
[TBL] [Abstract][Full Text] [Related]
14. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes.
Lubner MG; Stabo N; Lubner SJ; del Rio AM; Song C; Halberg RB; Pickhardt PJ
Abdom Imaging; 2015 Oct; 40(7):2331-7. PubMed ID: 25968046
[TBL] [Abstract][Full Text] [Related]
15. Correlation between PET/CT parameters and KRAS expression in colorectal cancer.
Chen SW; Chiang HC; Chen WT; Hsieh TC; Yen KY; Chiang SF; Kao CH
Clin Nucl Med; 2014 Aug; 39(8):685-9. PubMed ID: 24978328
[TBL] [Abstract][Full Text] [Related]
16. Characterizing MRI features of rectal cancers with different KRAS status.
Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
[TBL] [Abstract][Full Text] [Related]
17. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis.
Jia LL; Zhao JX; Zhao LP; Tian JH; Huang G
Eur J Radiol; 2023 Jan; 158():110640. PubMed ID: 36525703
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival.
Miles KA; Ganeshan B; Griffiths MR; Young RC; Chatwin CR
Radiology; 2009 Feb; 250(2):444-52. PubMed ID: 19164695
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of using computed tomography texture analysis parameters as imaging biomarkers for predicting risk grade of gastrointestinal stromal tumors: comparison with visual inspection.
Choi IY; Yeom SK; Cha J; Cha SH; Lee SH; Chung HH; Lee CM; Choi J
Abdom Radiol (NY); 2019 Jul; 44(7):2346-2356. PubMed ID: 30923842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
